1AD 0.00% 2.5¢ adalta limited

If its not the right deal with Pharma they may choose the...

  1. 3,505 Posts.
    lightbulb Created with Sketch. 374
    If its not the right deal with Pharma they may choose the funding route and go Phase II alone to extract more value. Then partner or sell at Phase III (assuming P2 was a success) It can play out multiple ways both with pros and cons. 'Anchoring bias' is interesting and explains the posts here.
    Last edited by asx11: 27/03/24
 
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.